Digital Veeva Commercial Summit 2025: On quality data foundations an... At Veeva Commercial Summit this year, web editor Nicole Raleigh spoke with Karl Goossens, General Manager of OpenData Europe at Veeva Systems.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.